Genomma Lab Internacional Sab De Cv operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Genomma Lab Internacional Sab De Cv with three other
pharmaceutical manufacturers in Latin America:
sales of 2.97 billion Brazilian Reals [US$564.93 million]
of which 82%
was Diagnostic Medicine),
Instituto Hermes Pardini SA
(1.49 billion Brazilian Reals [US$284.03 million]
of which 100%
was auxiliary diagnostic support services), and
based in BRAZIL
(4.09 billion Brazilian Reals [US$777.34 million]
During the year ended December of 2020, sales at
Genomma Lab Internacional Sab De Cv were 13.87 billion Mexican Pesos (US$699.06 million).
increase of 9.1%
versus 2019, when the company's sales were 12.71 billion Mexican Pesos.